Fa Wang
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Neonatal Respiratory Health Research
-
- MicroRNA in disease regulation
Papers in
-
- Optical Imaging and Spectroscopy Techniques 3
- Radiopharmaceutical Chemistry and Applications 1
-
- Advanced Fluorescence Microscopy Techniques 2
- Co-authors
- Rachel L. Zemans (2 shared papers)Jing Yang (1 shared paper)Fu‐Ju Tian (1 shared paper)Xiaocui Li (1 shared paper)Yanxiang Cheng (1 shared paper)Yi Lin (1 shared paper)Xiaoling Ma (1 shared paper)Thomas Wang (6 shared papers)
- Journals
- Journal of Medicinal Chemistry (2 papers)The Journal of Pathology (1 paper)Journal of Clinical Investigation (1 paper)Bioconjugate Chemistry (1 paper)Antioxidants and Redox Signaling (1 paper)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Fa Wang
18 papers receiving 335 citations
Fa Wang's Hit Papers
Peers
Comparison fields: 5 of 51
- Pulmonary and Respiratory Medicine 113
- Cancer Research 28
- Aging 3
- Immunology 35
- Obstetrics and Gynecology 12
Countries citing papers authored by Fa Wang
This map shows the geographic impact of Fa Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fa Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fa Wang more than expected).
Fields of papers citing papers by Fa Wang
This network shows the impact of papers produced by Fa Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fa Wang. The network helps show where Fa Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fa Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Regulation of epithelial transitional states in murine and human pulmonary fibrosis Hit paper breakdown → | 2023 | 106 |
| 2 | 2016 | 52 | |
| 3 | 2011 | 46 | |
| 4 | 2021 | 26 | |
| 5 | 2024 | 18 | |
| 6 | 2018 | 16 | |
| 7 | 2017 | 14 | |
| 8 | 2025 | 12 | |
| 9 | 2017 | 10 | |
| 10 | 2019 | 10 | |
| 11 | Downregulated miRNA-22-3p promotes the progression and leads to poor prognosis of hepatocellular carcinoma through targeting CDKN2C. | 2021 | 9 |
| 12 | 2021 | 6 | |
| 13 | 2017 | 3 | |
| 14 | 2020 | 3 | |
| 15 | 2022 | 3 | |
| 16 | 2017 | 2 | |
| 17 | 2023 | 2 | |
| 18 | 2025 | 1 | |
| 19 | Advances in Research of miR-183 Family and Cancer | 2013 | 0 |
About Fa Wang
Fa Wang is a scholar working on Radiology, Nuclear Medicine and Imaging, Biophysics, Pulmonary and Respiratory Medicine, Cancer Research and Biomedical Engineering, having authored 19 papers that have together received 339 indexed citations. Recurring topics across this work include Optical Imaging and Spectroscopy Techniques (3 papers), Nanoplatforms for cancer theranostics (3 papers), Photodynamic Therapy Research Studies (2 papers), MicroRNA in disease regulation (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Advanced Fluorescence Microscopy Techniques (2 papers), Radiopharmaceutical Chemistry and Applications (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (113 citations), Cancer Research (28 citations), Aging (3 citations), Immunology (35 citations) and Obstetrics and Gynecology (12 citations). Fa Wang has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Rachel L. Zemans, Jing Yang, Fu‐Ju Tian, Xiaocui Li, Yanxiang Cheng, Yi Lin, Xiaoling Ma, Thomas Wang, Ye Zhao and Chun‐Bo Teng. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Pathology, Journal of Clinical Investigation, Bioconjugate Chemistry and Antioxidants and Redox Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.